Metraipolis › archive › dc_58fe0c009d02

Progress in RNA-Targeted Therapeutics for Human Diseases — Europe PMC PMID:41660305

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41660305
DOI
10.1002/mco2.70607
License (as archived)
solo-consultazione
Archived
2026-11-06T02:53:48.641Z
SHA-256 of the archived text
22be39603cfb90e00b4d7cf2796a43806e62b53087a27ab0a9c54b40732ba099
Stable URL of this page
https://metraipolis.com/documento/dc_58fe0c009d02

How to cite

Progress in RNA-Targeted Therapeutics for Human Diseases — Europe PMC PMID:41660305 — Europe PMC (en), https://europepmc.org/article/MED/41660305 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_58fe0c009d02 (Metraipolis archive dc_58fe0c009d02, sha256 22be39603cfb90e00b4d7cf2796a43806e62b53087a27ab0a9c54b40732ba099)
BibTeX
@misc{dc58fe0c009d02,
  title = {Progress in RNA-Targeted Therapeutics for Human Diseases — Europe PMC PMID:41660305},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41660305},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_58fe0c009d02; sha256 22be39603cfb90e00b4d7cf2796a43806e62b53087a27ab0a9c54b40732ba099},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41660305. Agents can read the archived copy with the MCP tool read_document.